Literature DB >> 28454316

Overexpression of N-cadherin and β-catenin correlates with poor prognosis in patients with nasopharyngeal carcinoma.

Hong Sun1, Mingyu Liu1, Xuewen Wu1, Chunguang Yang1, Yanni Zhang1, Zhenhang Xu1, Kelei Gao1, Fengjun Wang1.   

Abstract

An increasing amount of evidence demonstrates that epithelial-mesenchymal transition (EMT) is important in tumor invasion and metastases. The cell-cell adhesion molecule N-cadherin and the Wnt/β-catenin cascade protein β-catenin are two biomarkers of EMT. The present study aimed to measure the expression levels of N-cadherin and β-catenin in samples from patients with nasopharyngeal carcinoma (NPC) and evaluate their prognostic significance. N-cadherin and β-catenin mRNA was evaluated using reverse transcription-quantitative polymerase chain reaction in 26 NPC tissue samples and 8 nasopharyngeal epithelium samples. Protein expression of N-cadherin and β-catenin was also detected using immunohistochemistry in 128 archival NPC paraffin-embedded specimens. Finally, associations between clinical pathological parameters and prognostic values in NPC were evaluated. The results demonstrated that both the mRNA and protein levels of N-cadherin and β-catenin were significantly increased in NPC tissues compared with the controls. Enhanced expression of N-cadherin and β-catenin protein was strongly correlated with the status of lymph node metastasis and clinical stages in patients with NPC. Notably, high expression of N-cadherin and β-catenin proteins was significantly correlated with lower overall survival (OS) rate in patients with NPC. Finally, multivariate analysis demonstrated that expression of N-cadherin protein and clinical stages were independent prognostic factors for patients with NPC. Therefore, the present study demonstrated that N-cadherin and β-catenin expression may be used as potential prognostic biomarkers for patients with NPC.

Entities:  

Keywords:  N-cadherin; metastasis; nasopharyngeal carcinoma; prognosis; β-catenin

Year:  2017        PMID: 28454316      PMCID: PMC5403301          DOI: 10.3892/ol.2017.5645

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  32 in total

Review 1.  Role of N-cadherin in bone formation.

Authors:  Pierre J Marie
Journal:  J Cell Physiol       Date:  2002-03       Impact factor: 6.384

Review 2.  The phosphatidylinositol 3-Kinase AKT pathway in human cancer.

Authors:  Igor Vivanco; Charles L Sawyers
Journal:  Nat Rev Cancer       Date:  2002-07       Impact factor: 60.716

3.  Downregulation and abnormal expression of E-cadherin and beta-catenin in nasopharyngeal carcinoma: close association with advanced disease stage and lymph node metastasis.

Authors:  Z Zheng; J Pan; B Chu; Y C Wong; A L Cheung; S W Tsao
Journal:  Hum Pathol       Date:  1999-04       Impact factor: 3.466

4.  EGFR-dependent migration of glial cells is mediated by reorganisation of N-cadherin.

Authors:  Anne Rappl; Guido Piontek; Jürgen Schlegel
Journal:  J Cell Sci       Date:  2008-11-25       Impact factor: 5.285

5.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

6.  Characterization of matrix metalloproteinase-2 and -9, ADAM-10 and N-cadherin expression in human glioblastoma multiforme.

Authors:  Giuseppe Musumeci; Gaetano Magro; Venera Cardile; Marinella Coco; Rubina Marzagalli; Paola Castrogiovanni; Rosa Imbesi; Adriana Carol Eleonora Graziano; Fabio Barone; Michelino Di Rosa; Sergio Castorina; Alessandro Castorina
Journal:  Cell Tissue Res       Date:  2015-05-07       Impact factor: 5.249

7.  N-cadherin regulates mammary tumor cell migration through Akt3 suppression.

Authors:  S Chung; J Yao; K Suyama; S Bajaj; X Qian; O D Loudig; E A Eugenin; G R Phillips; R B Hazan
Journal:  Oncogene       Date:  2012-03-12       Impact factor: 9.867

8.  Mycobacterium bovis Bacillus Calmette-Guérin (BCG)-induced activation of PI3K/Akt and NF-kB signaling pathways regulates expression of CXCL10 in epithelial cells.

Authors:  Patricia Méndez-Samperio; Aline Pérez; Laura Rivera
Journal:  Cell Immunol       Date:  2009-01-31       Impact factor: 4.868

Review 9.  Epithelial to mesenchymal transition in head and neck squamous cell carcinoma.

Authors:  Ashley Smith; Theodoros N Teknos; Quintin Pan
Journal:  Oral Oncol       Date:  2012-11-19       Impact factor: 5.337

10.  Downregulated E-cadherin expression indicates worse prognosis in Asian patients with colorectal cancer: evidence from meta-analysis.

Authors:  Xin He; Zhigang Chen; Minyue Jia; Xiaoying Zhao
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

View more
  9 in total

1.  Long noncoding RNA SMAD5-AS1 acts as a microRNA-106a-5p sponge to promote epithelial mesenchymal transition in nasopharyngeal carcinoma.

Authors:  Ying-Juan Zheng; Jing-Yi Zhao; Tian-Song Liang; Ping Wang; Juan Wang; Dao-Ke Yang; Zhang-Suo Liu
Journal:  FASEB J       Date:  2019-09-26       Impact factor: 5.191

2.  Association of low expression of E-cadherin and β-catenin with the progression of early stage human squamous cervical cancer.

Authors:  Jing Jiang; Xinling Li; Xiangmei Yin; Jieying Zhang; Bin Shi
Journal:  Oncol Lett       Date:  2019-04-18       Impact factor: 2.967

3.  SATB1 protein is associated with the epithelial‑mesenchymal transition process in non‑small cell lung cancers.

Authors:  Natalia Glatzel-Plucinska; Aleksandra Piotrowska; Adam Rzechonek; Marzenna Podhorska-Okolow; Piotr Dziegiel
Journal:  Oncol Rep       Date:  2021-05-06       Impact factor: 3.906

4.  Plasma-derived Exosomes Reverse Epithelial-to-Mesenchymal Transition after Photodynamic Therapy of Patients with Head and Neck Cancer.

Authors:  Marie-Nicole Theodoraki; Saigopalakrishna S Yerneni; Cornelia Brunner; Joannis Theodorakis; Thomas K Hoffmann; Theresa L Whiteside
Journal:  Oncoscience       Date:  2018-04-29

5.  Anti-tumoral potential of MDA19 in human osteosarcoma via suppressing PI3K/Akt/mTOR signaling pathway.

Authors:  Bin Liu; Liang Xu; E-Nuo Dai; Jia-Xin Tian; Jian-Min Li
Journal:  Biosci Rep       Date:  2018-12-14       Impact factor: 3.840

6.  Distant Metastasis Risk Definition by Tumor Biomarkers Integrated Nomogram Approach for Locally Advanced Nasopharyngeal Carcinoma.

Authors:  Xinjuan Fan; Ya Xie; Haiyang Chen; Xiaobo Guo; Yan Ma; Xiaolin Pang; Yan Huang; Fang He; Shuai Liu; Yizhen Yu; Minghuang Hong; Jian Xiao; Xiangbo Wan; Ming Li; Jian Zheng
Journal:  Cancer Control       Date:  2019 Jan-Dec       Impact factor: 3.302

7.  Aberrant Expression of β-Catenin Correlates with Infiltrating Immune Cells and Prognosis in NSCLC.

Authors:  Hongmei Zheng; Yue Ning; Yang Yang; Yuting Zhan; Haihua Wang; Qiuyuan Wen; Jinwu Peng; Songqing Fan
Journal:  Pathol Oncol Res       Date:  2021-10-26       Impact factor: 3.201

Review 8.  The prognostic significance of β-Catenin expression in patients with nasopharyngeal carcinoma: A systematic review and meta-analysis.

Authors:  Liu-Qing Zhou; Jin-Xiong Shen; Tao Zhou; Chun-Li Li; Yao Hu; Hong-Jun Xiao
Journal:  Front Genet       Date:  2022-08-09       Impact factor: 4.772

9.  WNT8B as an Independent Prognostic Marker for Nasopharyngeal Carcinoma.

Authors:  Chawalit Ngernsombat; Pongphol Prattapong; Noppadol Larbcharoensub; Krittika Khotthong; Tavan Janvilisri
Journal:  Curr Oncol       Date:  2021-07-08       Impact factor: 3.677

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.